Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy
- 1 May 2012
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 92 (5), 650-661
- https://doi.org/10.1038/labinvest.2012.2
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2Hypertension, 2011
- ACE2: more of Ang-(1–7) or less Ang II?Current Opinion in Nephrology and Hypertension, 2011
- Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal diseaseCurrent Opinion in Nephrology and Hypertension, 2011
- Human Recombinant ACE2 Reduces the Progression of Diabetic NephropathyDiabetes, 2009
- Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase PathwayThe American Journal of Pathology, 2008
- ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic miceKidney International, 2007
- Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney InjuryThe American Journal of Pathology, 2007
- Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting EnzymeJournal of the American Society of Nephrology, 2006
- Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent GlomerulosclerosisThe American Journal of Pathology, 2006
- Angiotensin-Converting Enzyme II in the Heart and the KidneyCirculation Research, 2006